article thumbnail

GSK enters agreement with Canada for influenza vaccines

Pharmaceutical Technology

GlaxoSmithKline (GSK) has signed an agreement with the Government of Canada for pandemic and seasonal influenza vaccines to aid in protecting adults and children in the country. The company intends to supply both vaccines from its 230,000ft² Sainte-Foy facility in Quebec. .

article thumbnail

World’s first malaria vaccine rolled out in Cameroon

Express Pharma

Cameroon has kickstarted the world’s first routine vaccine programme against malaria. It is one of 20 African countries planning to introduce the drug this year, according to global vaccine alliance Gavi. The vaccine is designed to be administered to young children in four doses from around five months of age.

Vaccines 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Nuclear Pharmacist by Day, DJ by Night

Pharmacy Is Right For Me

I worked in Dallas from 95-2001, then moved to NYC, then years later went to the University of Colorado for the NTPD program and received the PharmD. When the monkeypox outbreak was happening here in NYC, I used my platform to be a source of information about vaccines and TPOXX treatments. What led you to this career path?

Hospitals 130
article thumbnail

3 steps for comprehensive patient collaboration

pharmaphorum

He joined Johnson & Johnson in 2001 as Director Corporate Communications. Later, he built the external relationships in the field of Hepatitis C, before becoming the Global Therapeutic Area Communications Leader Infectious Diseases and Vaccines. About the author. In that function, he initially worked in the field of oncology.

article thumbnail

NK cell immunotherapy: what’s next in clinical development?

European Pharmaceutical Review

The progress of the RNA technology and tumour specific vaccination will be also key to increase adaptive immunity against the tumour but also as it participates to the activation of the innate immunity through RNA sensing. He is a member of the company’s Executive Board.

article thumbnail

Top 20 Radiopharma Companies Based on Market Cap

PharmaShots

Market Cap: $29.30M Founded Year: 2001 Total Employees: ~20 Headquarters: Tokyo, Japan Stock Exchange: TYO Perseus Proteomics is a Japanese biotech company focused on developing antibodies by utilizing antibody technology to provide treatment options to patients worldwide.

Dosage 56
article thumbnail

ExeVir ready for clinic with variant-targeting llama antibody

pharmaphorum

SARS-CoV-2 is likely to stay endemic in the human population for the foreseeable future, ExeVir noted, with variants capable of evading immunity the most likely cause of the disease in the future as global vaccination programmes begin to take effect. ExeVir is not the first company to spin out of VIB to focus on camelid antibodies.